Rising Biosciences, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a RBII research report →
About the company
Rising BioSciences, Inc. develops and manufactures topical and oral pharmaceutical products, including medical marijuana products. The company is based in Sheridan, Wyoming.
- CEO
- Arthur Hall
- IPO
- 2000
- HQ
- Sheridan, WY, US
Price Chart
- Market Cap
- $4.99K
- P/E
- 0.21
- P/S
- 0.01
- P/B
- -0.01
- EV/EBITDA
- 6.64
- Div Yield
- 0.00%
- Gross Margin
- 57.32%
- Op Margin
- 36.33%
- Net Margin
- 6.36%
- ROE
- -4.43%
- ROIC
- -851.75%
- Revenue
- $782.28K · 377.77%
- Net Income
- $49.76K · 119.65%
- EPS
- $0.00 · 100.00%
- Op Income
- $284.17K
- FCF YoY
- 50.02%
- 52W High
- $0.00
- 52W Low
- $0.00
- 50D MA
- $0.00
- 200D MA
- $0.00
- Beta
- 33.79
- Avg Volume
- 318.39K
Get TickerSpark's AI analysis on RBII
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Our RBII coverage
Recent articles, reports, and earnings notes.
No research on RBII yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate RBII report →Similar companies
Peers in the same neighborhood.